Biohaven
BHVNNYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations
Market cap
$2.091 B
$13.85 -9.15%
Close of 6 Nov 2026
As of 6 Nov 2026, Biohaven (BHVN) has a market capitalization of $2.09B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
—
Not reported
Earnings
-$738.8M
Loss-making
Shares outstanding
151,058,781
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations, ranked by market cap
All 498 →- #93ImmunomeIMNM$2.13B
- #94Prestige Consumer HealthcarePBH$2.11B
- #95BiohavenBHVN$2.09B
- #96ZymeworksZYME$2.03B
- #97First Tracks BiotherapeuticsTRAX$1.92B
What if Biohaven were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Biohaven are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.